“Expanding and thriving companies like Helmer are the reason our state’s reputation as a hub for the life sciences industry continues to garner national attention,” said Dan Hasler, Secretary of Commerce and chief executive officer of the Indiana Economic Development Corporation. “Our world-class research universities and low-tax policies are helping to grow these innovative companies.”
Helmer, which currently has nearly 150 full-time employees in Indiana, has already begun hiring additional engineering, manufacturing, marketing and sales positions.
“We see this new facility as a key element in delivering products to market faster for our customers in over 100 countries, as well helping us attract and retain outstanding talent,” said Bruce King, president of Helmer. “We are thrilled that our headquarters is remaining in Noblesville given its central location for our workforce. This project could not have gone through without the help of the IEDC, Noblesville, Saxony and Verus, whose efforts were brought together by our partner on the project, Summit Real Estate.”
The Indiana Economic Development Corporation offered Helmer, Inc. up to $300,000 in conditional tax credits and based on the company’s job creation plans. These tax credits are performance-based, meaning until Hoosiers are hired, the company is not eligible to claim incentives. The city of Noblesville approved additional property tax abatement.
“It is really gratifying to see Helmer reinvest once again in Noblesville,” said Noblesville Mayor John Ditslear. “We work hard to help our city’s businesses grow and expand and are pleased that Helmer’s latest expansion will keep them in Noblesville and in our Corporate Campus. They are a very important part of our community.”
The Wall Street Journal recently cited Indianapolis as “one of the hottest spots for starting a new business” and a national hub for the life sciences industry. The Hoosier State has added more than 8,800 jobs in the life sciences industry in recent years and today some 825 medical-device companies, drug manufacturers and research labs call Indiana home.
